Sorin, a medical device company, has received CE Mark approval for its Intensia family of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT-D) devices. The Intensia family includes single-chamber ...
Tags: medical device, CRT-D Devices
The US Food and Drug Administration (FDA) advisory panel has recommended the expanded indication of Medtronic’s cardiac resynchronization therapy-pacemakers and -defibrillators (CRT-P and CRT-D) for the treatment of patients who ...
Biotronik, a manufacturer of cardiovascular medical technology, has introduced its Ilesto DX system, which offers the established benefits of the DX System in a thinner and smaller device. This launch follows the approval from the US Food ...
Tags: Biotronik, Ilesto DX System
Sorin Group, a Netherlands-based company, has received US FDA approval for the launch the Smartview remote monitoring solution for patients with implanted cardiac rhythm management (CRM) devices. Using the secure SMARTVIEW remote ...
Tags: Sorin Group, Monitoring Solution
Medtronic has gained CE mark for its Viva/Brava portfolio of cardiac resynchronization therapy with defibrillation (CRT-D) devices. The family of CRT-Ds features a new algorithm, called AdaptivCRT, which by preserving patients' normal ...
Tags: Medtronic, CE mark, CRT-D devices, AdaptivCRT, CRT treatment
Boston Scientific has obtained the CE mark approval for the extended longevity provided by its INCEPTA, ENERGEN, PUNCTUA, COGNIS and TELIGEN implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators ...